Jacquet Pierre
SEC insider (Form 3/4/5 filer). CIK 0001783451. Director at Mereo BioPharma Group plc (MREO). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in LONDON, X0.
Companies Jacquet Pierre has filed insider reports for
- Mereo BioPharma Group plc (MREO): Director
Jacquet Pierre
CIK: 0001783451
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mereo BioPharma Group plc
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
66K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
AwardDirectDeferred Restricted Stock Units
106.8K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectShare Options (Right to buy)
55K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
AwardDirectDeferred Restricted Stock Units
15.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 66,000 | - | - | Direct |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award Deferred Restricted Stock Units | 106,848 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Share Options (Right to buy) | 55,000 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award Deferred Restricted Stock Units | 15,243 | - | - | Direct |
1-4 of 4 transactions